MeSH D016481 - helicobacter infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Tetracycline | Tetracycline |  | 1982-01-01 |  |  |
| Abbott Biotherapeutics | Metronidazole | Metronidazole |  | 1983-11-18 |  |  |
| Tetracycline | Tetracycline |  | 1982-01-01 |  |  | |
| AbbVie | Clarithromycin | Biaxin |  | 1991-10-31 |  |  |
| Able Laboratories | Metronidazole | Metronidazole |  | 2003-06-25 |  |  |
| Accord Healthcare | Esomeprazole | Esomeprazole |  | 2015-09-25 |  |  |
| Ajanta Pharma | Clarithromycin | Clarithromycin |  | 2019-04-25 |  |  |
| Lansoprazole | Lansoprazole |  | 2016-10-14 |  |  | |
| Naproxen, Esomeprazole strontium | Naproxen Esomeprazole Magnesium |  | 2022-10-06 |  |  | |
| Omeprazole | Omeprazole Bicarbonate |  | 2016-07-15 |  |  | |
| Pantoprazole | Pantoprazole |  | 2023-02-09 |  |  | |
| Alembic Pharmaceuticals | Clarithromycin | Clarithromycin |  | 2022-01-31 |  |  |
| Metronidazole | Metronidazole |  | 2009-06-23 |  |  | |
| Alkem Laboratories | Esomeprazole strontium | Esomeprazole Magnesium |  | 2017-10-20 |  |  |
| Lansoprazole | Lansoprazole |  | 2019-01-18 |  |  | |
| Rabeprazole | Rabeprazole |  | 2018-04-24 |  |  |
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
86%6/7
Phase 3
89%24/27
Approved: 15Overall Success rate: 76%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
11
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use